Chemical modification of a specific inhibitor of nicotinamide N-methyltransferase to generate a membrane-permeable prodrug. Journal of Medicinal Chemistry , 61(3), 1366-1371
Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements
[DOI] [PMC free article] [PubMed] [Google Scholar] 134.Huang Y, He S, Li JZ, Seo Y-K, Osborne TF, Cohen JC, et al
Insulin sensitivity and glucose handling